Targeted Cellular Micropharmacies: Cells Engineered for Localized Drug Delivery

The recent emergence of engineered cellular therapies, such as Chimeric antigen receptor (CAR) CAR T and T cell receptor (TCR) engineered T cells, has shown great promise in the treatment of various cancers. These agents aggregate and expand exponentially at the tumor site, resulting in potent immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Gardner, Thomas J., Bourne, Christopher M., Dacek, Megan M., Kurtz, Keifer, Malviya, Manish, Peraro, Leila, Silberman, Pedro C., Vogt, Kristen C., Unti, Mildred J., Brentjens, Renier, Scheinberg, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465970/
https://www.ncbi.nlm.nih.gov/pubmed/32764348
http://dx.doi.org/10.3390/cancers12082175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465970/
https://www.ncbi.nlm.nih.gov/pubmed/32764348
http://dx.doi.org/10.3390/cancers12082175

Ejemplares similares